FDA Inspection 1222626 — Tiofarma B.V.
The FDA completed an inspection of Tiofarma B.V. on September 22, 2023 in Oud-Beijerland. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- September 22, 2023
- Fiscal Year
- 2023
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Oud-Beijerland (Netherlands)